ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Neurology

Top Neurology Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SYED SHAH M.D.

Neurology

10,788

$1.32M

722
404 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $249

RIAZ NASEER M.D.

Neurology

6,378

$608K

550
253 are 65+

15%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $249

LAWRENCE WILKIN MD

Neurology

5,703

$1.36M

195
50 are 65+

57%
patients receiving schedule two controlled substances

Avg: 2%

42%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$239
Average prescription price

Avg: $249

DAVID GELBER M.D.

Neurology

5,654

$3.98M

532
284 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$703
Average prescription price

Avg: $249

CLAUDE FORTIN MD

Neurology

5,337

$1.06M

543
297 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$198
Average prescription price

Avg: $249

FAROUK KHAN MD, PHD

Neurology

5,164

$1.22M

425
248 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$237
Average prescription price

Avg: $249

FAKHRE ALAM MD

Neurology

5,130

$817K

442
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$159
Average prescription price

Avg: $249

LORI GUYTON M.D.

Neurology

5,000

$1.41M

407
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$283
Average prescription price

Avg: $249

SHYAM PUPPALA MD

Neurology

4,901

$705K

452
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $249

DENNIS GARWACKI

Neurology

4,884

$3.62M

283
96 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$742
Average prescription price

Avg: $249

STEPHEN BURGER M. D.

Neurology

4,163

$855K

517
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$205
Average prescription price

Avg: $249

KOTESWARA NARLA M.D.

Neurology

4,125

$391K

409
263 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 3%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $249

THOMAS ZABIEGA MD

Neurology

3,675

$874K

215
109 are 65+

25%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$238
Average prescription price

Avg: $249

BRUCE DODT MD

Neurology

3,660

$885K

375
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$242
Average prescription price

Avg: $249

CHESTER DELACRUZ M.D.

Neurology

3,630

$672K

357
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $249

YEN-YI PENG MD

Neurology

3,606

$901K

241
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$250
Average prescription price

Avg: $249

SYED ALI M.D.

Neurology

3,592

$255K

450
266 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $249

ANDREW TA DO

Neurology

3,549

$739K

311
228 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 3%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $249

SAJJAN NEMANI MD

Neurology

3,492

$478K

297
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$137
Average prescription price

Avg: $249

GENE CHENG M.D.

Neurology

3,319

$416K

356
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$125
Average prescription price

Avg: $249

JENNIFER PALLONE D.O.

Neurology

3,312

$474K

328
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $249

DOUGLAS SULLIVANT MD

Neurology

3,264

$869K

269
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$266
Average prescription price

Avg: $249

JORGE ASCONAPE MD

Neurology

3,226

$812K

257
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$252
Average prescription price

Avg: $249

BORISLAV NIKOLOV M.D.

Neurology

3,155

$694K

330
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $249

MIGUEL SANGUINO MD

Neurology

3,044

$543K

207
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$178
Average prescription price

Avg: $249

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank